Ecolab (NYSE:ECL) met Q1 2026 EPS forecasts at $1.70 with a slight Revenue beat, delivering 13% adjusted EPS growth. Global High-Tech and Life Sciences surged while an energy Surcharge positions the company to offset Commodity headwinds by end of Q2.

Key Highlights

  • Adjusted diluted EPS grew 13% year-over-year to $1.70, meeting consensus, with Revenue of $4.07 billion slightly exceeding the $4.03 billion forecast.
  • Global High-Tech and digital both grew more than 20%, driven by AI infrastructure Demand and data centre expansion.
  • Life Sciences accelerated to 11% growth, with bioprocessing Revenue more than doubling year-over-year.
  • An energy Surcharge implemented on April 1 is expected to fully offset the dollar impact of Commodity cost increases by end of Q2 2026.
  • Full-year adjusted diluted EPS growth guidance of 12% to 15% was reaffirmed, excluding short-term impact from the pending CoolIT Acquisition.

A Strong Start With a Known Headwind Ahead

Ecolab (NYSE:ECL) opened 2026 with solid momentum, delivering 4% Organic Sales growth and 70 basis points of Operating Income Margin expansion to 16.8%. The performance was driven by 3% value pricing and 1% Volume growth, with the company's growth engines outperforming meaningfully relative to its core portfolio. Despite Commodity cost pressures stemming from the Middle East conflict, management expressed confidence in navigating the environment, citing a playbook refined through prior cycles including a 50% Commodity cost increase in 2022 that was successfully absorbed.

Growth Engines Pulling Away

The standout performers in Q1 were Global High-Tech and Life Sciences, both of which management characterised as high-Margin, high-growth businesses with minimal energy cost exposure. Global High-Tech, encompassing water management and cooling solutions for semiconductor fabs and data centres, grew more than 20%. The Ovivo Acquisition, which expands Ecolab's ultrapure water capabilities for microelectronics, is tracking above expectations with a Backlog higher than initially anticipated, supported by a pipeline of 17 new semiconductor fabs expected to open globally by 2030.

Life Sciences delivered 11% growth, with the bioprocessing segment more than doubling Revenue year-over-year. Management described this as the step-change performance the Business had been building toward, and guided for sustained double-digit growth supported by new capacity coming online in the second half of 2026. Operating Income margins in Life Sciences are expected to approach 30% over the next few years, with mid-20s margins anticipated in the near term as Investment continues.

Pest Elimination grew 7%, driven by share gains from the One Ecolab initiative and early commercial traction from the Pest Intelligence offering, which leverages approximately 700,000 connected smart devices. The company expects to reach one million connected devices by year-end, with the full Business expected to transition to a Pest Intelligence model over three to four years.

Energy Surcharge and the Q2 Transition

Commodity costs are expected to increase approximately 8% to 9% in Q2 2026, affecting approximately one-third of Ecolab's raw material base. The company implemented a broad energy Surcharge effective April 1, covering all customers across all businesses and geographies. Management guided that Surcharge benefits would build through Q2, with the full dollar impact of higher Commodity costs expected to be offset as the company exits the quarter.

As a result, Q2 EPS growth will be reduced by a few percentage points versus the underlying 12% to 15% range. The second half is expected to see Organic Sales growth of 6% to 7%, gross margins stabilising and, excluding Ovivo, expanding 70 to 80 basis points. Full-year guidance remains unchanged.

CoolIT Acquisition Adds a Near-Term EPS Drag but Structural Upside

The pending CoolIT Acquisition, a direct-to-chip liquid cooling platform for AI data centres, is expected to close in Q3 2026, subject to regulatory approval. Once closed, it will reduce quarterly adjusted EPS by approximately $0.20 in the second half of 2026 due to financing costs and non-cash Amortisation. This impact is expected to neutralise in 2027 as Nalco-related Amortisation rolls off. Management noted CoolIT's Q1 2026 Revenue growth was tracking well ahead of the 30% originally disclosed at Acquisition, with actual performance approaching triple-digit growth rates.

Conclusion

Ecolab's Q1 2026 results confirm that its portfolio shift toward high-growth, high-Margin, and energy-insulated businesses is compounding effectively. The energy Surcharge creates a defined transition in Q2, but the company's track record of executing through Commodity cycles and its accelerating growth engines in High-Tech and Life Sciences provide a credible path to delivering the full-year guidance and the 20% Operating Income Margin target by 2027.